comprehensive -WSS

comprehensive

author：explore 2025-10-01 02:28:06 - browse：299

Is no one safe from the FTC? Has Pfizer bottomed out? And is biotech finally back?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we delve into the fallout over the FTC’s move to block what looked like a humdrum biotech deal between Sanofi and Maze Therapeutics, a surprising twist that leaves an unanswered question. We also discuss the latest news in the life sciences, including Pfizer’s downbeat future, Vertex Pharmaceuticals’ next big thing, and a newly minted biotech VC with a very famous name.

For more on what we cover, here’s the FTC news; here’s more from Maze Therapeutics; here’s the Pfizer news; here’s the latest on Vertex; here’s the story behind its pain drug; here’s the Reed Jobs profile; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Cancer drug shortages should be causing more outrage
Next article： Poor hospice wound care hurts patients and families

WSS

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

Morphosys mixed study results for blood cancer drug

Ransomware attacks on hospitals: Study outlines patient impact

BMS, looking to build heart drug business, turns to AI for diagnosis

David Sabatini, ex

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

focus

comprehensive

explore

Guidelines to prevent youth baseball injuries need more muscle

Indictment alleges Trump's ex

Guidelines to prevent youth baseball injuries need more muscle

Idaho college killings prosecutors challenge defense's grand jury claims

State Dept. review finds Biden bears some blame for Afghanistan failures

Bird flu researchers hone in on Finland’s mink farms

Duchenne breakthrough therapy leaves behind pioneering families

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

In Memoriam: Notable people who died in 2023

Hospitals are dialing back on venture capital investing

hotspot

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

Bird flu researchers hone in on Finland’s mink farms

Congress must reauthorize a committee to support older Americans

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

Montana youths win climate lawsuit against state for promoting fossil fuels

Hospitals are dialing back on venture capital investing

explore

knowledge

Wikipedia

focus